NCITA Nuclear Medicine in Oncology Workshop – Introduction to Radiopharmacy

NCITA is a network of medical imaging experts and scientists across nine leading cancer imaging institutions across the UK, and we are building a unified infrastructure for discovery, validation and adoption of cancer imaging biomarkers into clinical trials and the NHS.

On the 27th April 2021, NCITA held a workshop on ‘Nuclear Medicine in Oncology’. The workshop provided a detailed overview of nuclear medicine in oncology, and a mix of researchers, students and managers joined the workshop to learn more about this area.

In the second of five talks, Dr Jennifer Young, Research Associate in Translational Radiopharmacy in the NCITA Imaging QA/QC unit (King’s College London) gives an ‘Introduction to Radiopharmacy’. Jennifer covers the aseptic manufacture of radiopharmaceuticals labelled with short life radionuclides, radiotracer design, the generation of radiometals within a radiopharmacy and generator production of radionuclides. Jennifer also discusses quality control and quality assurance procedures, synthesis failures, and an overview of staff who work in radiopharmacy.

For more of our webinars and workshops please visit: https://ncita.org.uk/online-materials